quantum-r: transfusion independence in patients with flt3-itd-mutated r/r aml treated with quiza...
Published 4 years ago • 40 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
5:04
clinical outcomes of patients with flt3-itd-mutated r/r aml undergoing hsct after quizartinib or...
-
4:09
quantum-r: quizartinib looks promising for flt3-itd mutated aml
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib
-
2:35
quizartinib for frontline flt3-itd aml: updated results from the quantum-first trial
-
3:31
update on quantum-first: quizartinib soc chemotherapy & as continuation therapy in flt3-itd aml
-
2:54
quantum-first: association between flt3-itd-specific mrd clearance and survival in patients with aml
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
3:35
quizartinib advances overall survival in acute myeloid leukaemia patients
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
4:35
admiral trial results: gilteritinib versus salvage chemotherapy in patients with flt3-mutated re...
-
0:45
dr. roboz on the quantum-r trial in aml
-
1:39
quantum-first: flt3-itd-specific mrd clearance is associated with improved os in newly diagnosed aml
-
1:50
mechanisms of gilteritinib resistance in flt3-mutated aml
-
3:23
quizartinib improves overall survival in adult patients with flt3-itd acute myeloid leukaemia
-
3:42
further analysis of quantum-first: the impact of allo-hct combined with quizartinib in flt3-itd aml
-
10:15
quizartinib for flt3-mutated aml
-
2:26
improving outcomes for flt3-mutated r/r aml
-
0:35
management & outcome of patients with cbf aml and flt3-itd
-
3:20
azacitidine, venetoclax and gilteritinib in previously untreated and r/r flt3-mutated aml